Curiously, recent sequencing studies and expression analyses, including the work presented here, have revealed distinct subsets of breast cancer with unexpectedly high PTEN expression levels and that correlate with upregulation of the PI3K signaling (58), thus suggesting a complex, yet unresolved, relationship between PTEN abundance and PI3K signaling activation. The gene discussed is PIK3CA; the disease is breast cancer.